Tal Gilat
Co-founder & CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Neurogenesis
Former names:
Neurodegenerative Disease Cell Therapy
Stealth Mode
Neurogenesis
Neurogenesis Overview
NeuroGenesis is a clinical-stage cellular therapy company that focuses on utilizing a proprietary subpopulation of bone marrow stem cells. These cells are specifically selected and enhanced to become remyelinating and regenerative biofactory cells. The company's platform, NG CELL technology, is specifically designed to treat central nervous system diseases, such as progressive multiple sclerosis and amyotrophic lateral sclerosis.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Neurogenesis Climate Tech relevance
null
Companies you might be interested in
Driven by Finder AI
-
Stem Cell MedicineStem Cell Therapeutic Technology11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
Nano24Next-generation of ImmunomodulatorsAre these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar? -
Hopec PharmaImmunotherapy Treatment for Bladder Cancer1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
DK
N
Contact Team
Affiliated Organizations
(null)Web & social links
https://neurogenesis-cell.com/
Locations
Israel
Tuval St 11, Ramat Gan, Israel
Offices Abroad
410 White Spruce Blvd, Rochester, NY 14623, USA
Photos & videos
(0)No Data, yet.
Sorry, no content found under this section.
Neurogenesis Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Neurogenesis Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
A Round
$6.66M
Mar 2022
3
Investors
$6.66M
Non-Equity Funding
Mergers and Acquisitions
Neurogenesis Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
A Round
$6.66M
Mar 2022
3
Investors
$6.66M
Neurogenesis News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
May 26, 2026
www.prnewswire.com
From smart agriculture to mental health: These are the New U.S.-Israel projects set to receive $7.5 million from the BIRD Foundation
null
Related Content
Neurogenesis Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
Stem Cell MedicineStem Cell Therapeutic Technology11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
Nano24Next-generation of ImmunomodulatorsAre these companies similar?
-
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar? -
Hopec PharmaImmunotherapy Treatment for Bladder Cancer1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar?
Neurogenesis Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,